Syndax Pharmaceuticals, Inc. (SNDX): Price and Financial Metrics

Syndax Pharmaceuticals, Inc. (SNDX): $20.05

0.78 (+4.05%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

SNDX Price/Volume Stats

Current price $20.05 52-week high $25.34
Prev. close $19.27 52-week low $11.22
Day low $19.40 Volume 2,837,100
Day high $20.32 Avg. volume 1,113,363
50-day MA $20.68 Dividend yield N/A
200-day MA $19.23 Market Cap 1.70B

SNDX Stock Price Chart Interactive Chart >


Syndax Pharmaceuticals, Inc. (SNDX) Company Bio


Syndax Pharmaceuticals, Inc., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics in oncology. The company was founded in 2005 and is based in Waltham, Massachusetts.


SNDX Latest News Stream


Event/Time News Detail
Loading, please wait...

SNDX Latest Social Stream


Loading social stream, please wait...

View Full SNDX Social Stream

Latest SNDX News From Around the Web

Below are the latest news stories about SYNDAX PHARMACEUTICALS INC that investors may wish to consider to help them evaluate SNDX as an investment opportunity.

With 85% ownership of the shares, Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) is heavily dominated by institutional owners

Key Insights Institutions' substantial holdings in Syndax Pharmaceuticals implies that they have significant influence...

Yahoo | December 23, 2023

Syndax Announces Closing of Public Offering of Common Stock and Exercise in Full of the Underwriters' Option to Purchase Additional Shares

Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced the closing of its previously announced underwritten public offering of 12,432,431 shares of its common stock, which includes the exercise in full of the underwriters' option to purchase 1,621,621 additional shares. The public offering price of each share of common stock was $18.50. The aggregate gross pro

Yahoo | December 19, 2023

12 Most Promising Cancer Stocks According to Analysts

In this piece, we will take a look at the 12 most promising cancer stocks according to analysts. If you want to skip our overview of the latest trends in the cancer treatment sector, then you can take a look at the 5 Most Promising Cancer Stocks According to Analysts. The advent of technology and […]

Yahoo | December 18, 2023

Syndax Announces Pricing of $200 Million Public Offering of Common Stock

Syndax Pharmaceuticals, Inc. ("Syndax" or the "Company") (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced the pricing of an underwritten public offering of 10,810,810 shares of its common stock. The public offering price of each share of common stock is $18.50. The aggregate gross proceeds from this offering are expected to be approximately $200.0 million, before deducting underwriting discounts and commissions and

Yahoo | December 15, 2023

Syndax Announces Proposed $150 Million Public Offering of Common Stock

Syndax Pharmaceuticals, Inc. ("Syndax" or the "Company") (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that it plans to offer and sell, subject to market and other conditions, $150 million of shares of its common stock in an underwritten public offering. Syndax also expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of shares of common stock sold in the public offe

Yahoo | December 14, 2023

Read More 'SNDX' Stories Here

SNDX Price Returns

1-mo -1.13%
3-mo -10.65%
6-mo -6.00%
1-year -4.16%
3-year 10.47%
5-year 137.56%
YTD -7.22%
2023 -15.09%
2022 16.26%
2021 -1.57%
2020 153.30%
2019 97.30%

Continue Researching SNDX

Here are a few links from around the web to help you further your research on Syndax Pharmaceuticals Inc's stock as an investment opportunity:

Syndax Pharmaceuticals Inc (SNDX) Stock Price | Nasdaq
Syndax Pharmaceuticals Inc (SNDX) Stock Quote, History and News - Yahoo Finance
Syndax Pharmaceuticals Inc (SNDX) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!